Paxlovid (nirmatrelvir/ritonavir) is the primary oral COVID antiviral. Is Paxlovid safe in pregnancy has limited but generally acceptable data, with treatment recommended for high-risk pregnant patients with COVID. Always discuss with your OB/GYN.
Pregnancy considerations
- Limited pregnancy-specific data (newer medication)
- Animal studies don’t show major concerns
- Ritonavir component has substantial pregnancy data from HIV use
- Pregnant patients are high-risk for severe COVID
Risk-benefit in pregnancy
Pregnant patients face higher risk of:
- Severe COVID
- ICU admission
- Maternal mortality
- Preterm birth
Treating COVID with Paxlovid likely benefits despite limited pregnancy data. Major medical organizations recommend Paxlovid for high-risk pregnant patients with COVID.
Drug interactions
Paxlovid (especially ritonavir component) has many drug interactions. Review all medications with prescriber.
Paxlovid in breastfeeding
Considered acceptable, particularly given the maternal benefit. Limited data.
Frequently Asked Questions
Should I take Paxlovid if I have COVID and am pregnant?
Generally yes if high-risk and within 5 days of symptoms. Discuss with OB/GYN promptly.
Is Paxlovid riskier than COVID in pregnancy?
Generally not. Severe COVID poses substantial pregnancy risks.
What about other COVID treatments?
Monoclonal antibodies and remdesivir also options. Paxlovid usually first choice.
Can I breastfeed on Paxlovid?
Generally acceptable.
How quickly should treatment start?
Within 5 days of symptom onset for maximum benefit.
The bottom line on Paxlovid in pregnancy
Paxlovid generally recommended for high-risk pregnant patients with COVID despite limited pregnancy data. Benefits typically outweigh risks. Discuss with OB/GYN promptly if COVID positive.